Evidence map›Paper›PMID 41267017›Full record

ArticleNutrition journal2025

Combined association between phenotypic age acceleration and dietary fiber intake with mortality in middle-aged and elderly cancer survivors.

Huanrui Zhang, Wen Tian, Guoxian Qi, Baosen Zhou, Yujiao Sun

Abstract read
In one paragraph

Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huanrui ZhangDepartment of Geriatrics, The First Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China.
Wen TianDepartment of Geriatrics, The First Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China.
Guoxian QiDepartment of Geriatrics, The First Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China.
Baosen ZhouDepartment of Clinical Epidemiology and Evidence-Based Medicine, The First Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China.
Yujiao SunDepartment of Geriatrics, The First Hospital of China Medical University, NO.155 Nanjing North Street, Heping Ward, Shenyang, 110001, China. yjsun@cmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study examined the associations of phenotypic age (PhenoAge) acceleration and dietary fiber intake with mortality risk among middle-aged and older adult cancer survivors.

methodsThis study analyzed data from 2958 cancer survivors aged 40 and older using National Health and Nutrition Examination Survey (NHANES) 2003-2018. Dietary fiber intake was assessed via two 24-hour dietary recalls, calculated using the USDA database. High dietary fiber intake was defined as the top quartile. Biological age was estimated using the PhenoAge algorithm with 8 biomarkers, defining accelerated aging as PhenoAge >0. Mortality status was determined through linkage with the National Death Index. Cox regression models and Kaplan-Meier curves were used to examine the separate and combined association of dietary fiber intake and PhenoAge acceleration on mortality, adjusting for multiple covariates. Multiplicative interaction was assessed by including a product term in the cox regression models, while additive interaction was examined using the relative excess risk due to interaction (RERI) and the attributable proportion (AP). Restricted cubic spline models were applied to estimate the linear/non-linear relationships between PhenoAge acceleration, dietary fiber intake, and mortality risk. Sensitivity analysis was used to validate previous findings.

resultsThe study included 2,958 cancer survivors with a baseline mean age of 65.58 years. During a 17-year follow-up (median [IQR]: 79 [42-125] months), 915 participants died. Accelerated aging had elevated risk of all-cause (HR (95% CI), 2.12 (1.78, 2.52), P<0.001), cardiovascular (HR (95% CI), 1.72 (1.18, 2.51), P=0.005), cancer (HR (95% CI), 2.68 (2.00, 3.58), P<0.001), and non-cancer/non-cardiovascular mortality (HR (95% CI), 2.04 (1.58, 2.63), P<0.001). Low dietary fiber intake was linked to increased all-cause (HR (95% CI), 1.31 (1.05, 1.63), P=0.015), cancer (HR (95% CI), 1.59 (1.11, 2.27), P=0.011), and non-cancer/non-cardiovascular mortality (HR (95% CI), 1.64 (1.11, 2.43), P=0.013). The "Accelerated aging & low dietary fiber" group had the highest all-cause mortality risk (HR (95% CI), 2.45 (1.81, 3.33), P<0.001), cancer mortality risk (HR (95% CI), 3.40 (2.16, 5.37), P<0.001), non-cancer/non-cardiovascular mortality risk (HR (95% CI), 3.18 (1.91, 5.29), P<0.001), compared to the "Non-accelerated aging & high dietary fiber" group. Furthermore, a significant additive interaction was observed between PhenoAge acceleration and low dietary fiber intake on cancer mortality (RERI = 1.44, 95% CI: 0.23-2.64; AP = 0.42, 95% CI: 0.08-0.76). The results of the sensitivity analysis excluding samples that died within two years are consistent with the main analysis.

conclusionsPhenoAge acceleration and lower dietary fiber intake are associated with increased mortality risk in middle-aged and elderly cancer survivors. Notably, dietary fiber intake significantly modified the association between PhenoAge acceleration and cancer mortality.

Indexed as

AgingCancer SurvivorsDietDietary FiberNeoplasmsAdultAgedFemaleHumansMaleMiddle AgedNutrition SurveysPhenotypeProportional Hazards ModelsRisk FactorsDietary FiberAccelerated agingAdultCancer survivorDietary fiberMortality

Identifiers

PMID41267017
PMCPMC12632119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.